Back to Markets
NTIntellia Therapeutics Inc

Intellia Therapeutics Inc

NTLANASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$14.07

+0.3900 (+2.85%)

As of 05/29/26 EDT · USD

Compare
Low: $6.92Current: $14.07High: $28.25

Key Statistics

Open

$13.70

Day High

$14.30

Day Low

$13.12

Prev. Close

$13.68

VolumeShares traded today.

5.10M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$1.97B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-3.98

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$28.25

52W LowLowest price over the past 52 weeks.

$6.92

50D MAAverage closing price over the last 50 trading days.

$13.57

200D MAAverage closing price over the last 200 trading days.

$13.28

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+13.7%

1M

+13.1%

6M

+64.6%

YTD

+52.8%

1Y

+96.5%

About

Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia's ex vivo programs use CRISPR to create the therapy by using engineered human cells to treat cancer and autoimmune diseases.

www.intelliatx.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade NTLA

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.